International Journal of Cardiology
Volume 125, Issue 1 , Pages 79-84 , 28 March 2008

Association between serum resistin and carotid intima media thickness in hypertension patients

  • Hyun-Joon Shin

      Affiliations

    • Cardiology Division, Yonsei Cardiovascular Center, Yonsei University College of Medicine, SeodaemunGu 120-752, Seoul, Republic of Korea
    • These authors contributed equally to this article.
    • ,
  • Sungha Park

      Affiliations

    • Cardiology Division, Yonsei Cardiovascular Center, Yonsei University College of Medicine, SeodaemunGu 120-752, Seoul, Republic of Korea
    • Cardiovascular Genome Center, Yonsei Cardiovascular Center, Yonsei University College of Medicine, Seoul, Republic of Korea
    • These authors contributed equally to this article.
    • ,
  • Se-Jung Yoon

      Affiliations

    • Cardiology Division, Yonsei Cardiovascular Center, Yonsei University College of Medicine, SeodaemunGu 120-752, Seoul, Republic of Korea
    • ,
  • Dae Shik Choi

      Affiliations

    • Cardiology Division, Yonsei Cardiovascular Center, Yonsei University College of Medicine, SeodaemunGu 120-752, Seoul, Republic of Korea
    • ,
  • Deok-Kyu Cho

      Affiliations

    • Cardiovascular Center, Cardiology Division, Department of Internal Medicine, Myongji Hospital, Kwandong University College of Medicine, Goyang, Gyeonggi, Republic of Korea
    • ,
  • Jung-Sun Kim

      Affiliations

    • Cardiology Division, Yonsei Cardiovascular Center, Yonsei University College of Medicine, SeodaemunGu 120-752, Seoul, Republic of Korea
    • ,
  • Young-Guk Ko

      Affiliations

    • Cardiology Division, Yonsei Cardiovascular Center, Yonsei University College of Medicine, SeodaemunGu 120-752, Seoul, Republic of Korea
    • ,
  • Donghoon Choi

      Affiliations

    • Cardiology Division, Yonsei Cardiovascular Center, Yonsei University College of Medicine, SeodaemunGu 120-752, Seoul, Republic of Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 2 2228 8449; fax: +82 2 393 2041.
    • ,
  • Yangsoo Jang

      Affiliations

    • Cardiology Division, Yonsei Cardiovascular Center, Yonsei University College of Medicine, SeodaemunGu 120-752, Seoul, Republic of Korea
    • Cardiovascular Genome Center, Yonsei Cardiovascular Center, Yonsei University College of Medicine, Seoul, Republic of Korea
    • ,
  • Namsik Chung

      Affiliations

    • Cardiology Division, Yonsei Cardiovascular Center, Yonsei University College of Medicine, SeodaemunGu 120-752, Seoul, Republic of Korea

Received 22 August 2006 ,Revised 3 January 2007 ,Accepted 17 February 2007.

References 

  1. Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin Nephrol Hypertens. 2006;15:152–158
  2. Brasier AR, Recinos A, Eledrisi MS. Vascular inflammation and the renin–angiotensin system. Arterioscler Thromb Vasc Biol. 2002;22:1257–1266
  3. Schiffrin EL, Touyz RM. From beside to bench to bedside: role of renin–angiotensin–aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol. 2004;287:H435–H446
  4. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol. 2004;122:339–352
  5. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res. 2001;89:763–771
  6. Nakashima Y, Raines EW, Plump AS, et al. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis prone sites on the endothelium in the ApoE deficient mouse. Arterioscler Thromb Vasc Biol. 1998;18:842–851
  7. Ballantyne CM, Entman ML. Soluble adhesion molecules and the search for biomarkers for atherosclerosis. Circulation. 2002;106:766–767
  8. Lind L, Berne C, Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens. 1995;13:1457–1462
  9. Fantuzzi G. Adipose tissue, adipocytokines, and inflammation. J Allergy Clin Immunol. 2005;115:911–919
  10. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab. 2004;89:2563–2568
  11. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens. 2002;20:159–169
  12. Ferrieres J, Elias A, Ruidavets JB, et al. Carotid intima-media thickness and coronary heart disease risk factors in low-risk population. J Hypertens. 1999;17:743–748
  13. Pannacciulli N, Rizzon P, De Pergola G, Giorgino F, Ciccone M, Giorgino R. Effect of family history of type 2 diabetes on the intima-media thickness of the common carotid artery in normal weight, overweight, and obese glucose tolerant young adults. Diabetes Care. 2003;26:1230–1234
  14. Mannami T, Baba S, Ogata J. Strong and significant relationship between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population. Arch Intern Med. 2001;160:2297–2303
  15. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. For the cardiovascular health study collaborative research group. N Engl J Med. 1999;340:14–22
  16. Chambless LE, Folsom AR, Clegg LX, et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities(ARIC) study. Am J Epidemiol. 2000;151:478–487
  17. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307–312
  18. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111:932–939
  19. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med. 2004;255:439–447
  20. Savage DB, Sewter CP, Klenk ES, et al. Resistin/Fizz 3 expression in relation to obesity and peroxisome proliferators activated receptor gamma action in humans. Diabetes. 2001;50:2199–2202
  21. Burnett MS, Lee CW, Kinnaird TD, et al. The potential role of resistin in atherogenesis. Atherosclerosis. 2005;182:241–248
  22. Jung HS, Park KH, Cho YM, et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res. 2006;69:76–85
  23. Burnett MS, Devaney JM, Adenika RJ, Lindsay R, Howard BV. Cross sectional associations of resistin, coronary heart disease, and insulin resistance. J Clin Endocrinol Metab. 2006;91:64–68
  24. Verma S, Li SH, Wang CH, et al. Resistin promotes endothelial cell activation: further evidence of adipocytokine-endothelial interactions. Circulation. 2003;108:736–740
  25. Kunnari A, Ukkola O, Päivänsalo M, Kesäniemi YA. High plasma resistin level is associated with enhanced high sensitive C-reactive protein and leukocytes. J Clin Endocrinol Metab. 2006;91:2755–2760
  26. Bots ML, Evans GW, Riley WA, Grobbee DE. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke. 2003;34:2985–2994
  27. Pischon T, Bamberger CM, Kratzsch J, et al. Association of plasma resistin levels with coronary heart disease in women. Obes Res. 2005;13(10):1764–1771

☆ This work was supported by a grant from the ministry of Health and Welfare of the Republic of Korea (A000385) and by a grant of the Seoul R&BD program, Republic of Korea (10526).

PII: S0167-5273(07)00518-9

doi: 10.1016/j.ijcard.2007.02.028

International Journal of Cardiology
Volume 125, Issue 1 , Pages 79-84 , 28 March 2008

Article Tools

* Image Usage & Resolution